A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

Douillard, 2000, Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial, Lancet, 355, 1041, 10.1016/S0140-6736(00)02034-1 Saltz, 2000, Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer, Irinotecan Study Group. N Engl J Med, 343, 905, 10.1056/NEJM200009283431302 Borner, 2002, Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin. A randomised crossover trial in advanced colorectal cancer, Eur J Cancer, 38, 349, 10.1016/S0959-8049(01)00371-9 Van Cutsem, 2001, Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study, J Clin Oncol, 19, 4097, 10.1200/JCO.2001.19.21.4097 Twelves, 2002, Capecitabine as first-line treatment in colorectal cancer. Pooled data from two large, phase III trials, Eur J Cancer, 38, 15, 10.1016/S0959-8049(01)00415-4 Hoff, 2001, Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study, J Clin Oncol, 19, 2282, 10.1200/JCO.2001.19.8.2282 Rothenberg, 1996, Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer, J Clin Oncol, 14, 1128, 10.1200/JCO.1996.14.4.1128 Armand, 1996, Rationale for the dosage and schedule of CPT-11 (irinotecan) selected for phase II studies, as determined by European phase I studies, Ann Oncol, 7, 837, 10.1093/oxfordjournals.annonc.a010763 Fuchs, 2003, Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer, J Clin Oncol, 21, 807, 10.1200/JCO.2003.08.058 Tewes, 2003, Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study dagger, Ann Oncol, 14, 1442, 10.1093/annonc/mdg376 Bajetta, 2004, Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma, Cancer, 100, 279, 10.1002/cncr.11910 Borner, 1998, The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK), Ann Oncol, 9, 535, 10.1023/A:1008270916325 Bernhard, 1999, Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK), Ann Oncol, 10, 775, 10.1023/A:1008311918967 Bernhard, 2002, Patients' estimation of overall treatment burden: why not ask the obvious?, J Clin Oncol, 20, 65 Bernhard, 2001, Clinical relevance of single item quality of life indicators in cancer clinical trials, Br J Cancer, 84, 1156, 10.1054/bjoc.2001.1785 Simon, 1989, Optimal two-stage designs for phase II clinical trials, Control Clin Trials, 10, 1, 10.1016/0197-2456(89)90015-9 Clopper, 1934, The use of confidence or fiducial limits illustrated in the case of binomial, Biometrika, 26, 404, 10.1093/biomet/26.4.404 Kohne, 2002, Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients, Ann Oncol, 13, 308, 10.1093/annonc/mdf034 Burris, 2004, Continuous flat-dose capecitabine plus weekly irinotecan: an alternative first-line treatment for metastatic colorectal cancer, Proceedings of ASCO Gastrointestinal Cancers Symposium, 1 Gold, 2003, Capecitabine and irinotecan as 1st line therapy for patients with metastatic colorectal cancer: Phase II study preliminary results, Proc Am Soc Clin Oncol, 22 Kerr, 2002, A phase I/II study of CPT-11 in combination with capecitabine as first line chemotherapy for metastatic colorectal cancer (MCRC), Proc Am Soc Clin Oncol, 21 Patt, 2003, Capecitabine plus irinotecan for chemotherapy-naive patients with metastatic colorectal cancer, Proceedings of ASCO, 22 Buyse, 2000, Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer, Lancet, 356, 373, 10.1016/S0140-6736(00)02528-9 Hobday, 2002, Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma, J Clin Oncol, 20, 4574, 10.1200/JCO.2002.08.535